Mitran, B., Thisgaard, H., Rinne, S., Dam, J. H., Azami, F., Tolmachev, V., . . . Rosenström, U. (2019). Selection of an optimal macrocyclic chelator improves the imaging of prostate cancer using cobalt-labeled GRPR antagonist RM26. Sci Rep.
Chicago Style citaatMitran, Bogdan, Helge Thisgaard, Sara Rinne, Johan Hygum Dam, Frishta Azami, Vladimir Tolmachev, Anna Orlova, en Ulrika Rosenström. "Selection of an Optimal Macrocyclic Chelator Improves the Imaging of Prostate Cancer Using Cobalt-labeled GRPR Antagonist RM26." Sci Rep 2019.
MLA citatieMitran, Bogdan, et al. "Selection of an Optimal Macrocyclic Chelator Improves the Imaging of Prostate Cancer Using Cobalt-labeled GRPR Antagonist RM26." Sci Rep 2019.
Let op: Deze citaties zijn niet altijd 100% accuraat.